Auquier-Dunant Ariane, Mockenhaupt Maja, Naldi Luigi, Correia Osvaldo, Schröder Werner, Roujeau Jean-Claude
Department of Biostatistics and Epidemiology, Institut Gustave-Roussy, Villejuif, France.
Arch Dermatol. 2002 Aug;138(8):1019-24. doi: 10.1001/archderm.138.8.1019.
It was proposed that Stevens-Johnson syndrome and toxic epidermal necrolysis differed from erythema multiforme majus by the pattern and localization of skin lesions.
To evaluate the validity of this clinical separation.
Case-control study.
Active survey from 1989 to 1995 of 1800 hospital departments in Europe.
A total of 552 patients and 1720 control subjects.
Cases were sorted into 5 groups (erythema multiforme majus, Stevens-Johnson syndrome, Stevens-Johnson syndrome-toxic epidermal necrolysis overlap, toxic epidermal necrolysis, and unclassified erythema multiforme majus or Stevens-Johnson syndrome) by experts blinded as to exposure to drugs and other factors. Etiologic fractions for herpes and drugs obtained from case-control analyses were compared between these groups.
Erythema multiforme majus significantly differed from Stevens-Johnson syndrome, overlap, and toxic epidermal necrolysis by occurrence in younger males, frequent recurrences, less fever, milder mucosal lesions, and lack of association with collagen vascular diseases, human immunodeficiency virus infection, or cancer. Recent or recurrent herpes was the principal risk factor for erythema multiforme majus (etiologic fractions of 29% and 17%, respectively) and had a role in Stevens-Johnson syndrome (etiologic fractions of 6% and 10%) but not in overlap cases or toxic epidermal necrolysis. Drugs had higher etiologic fractions for Stevens-Johnson syndrome, overlap, or toxic epidermal necrolysis (64%-66%) than for erythema multiforme majus (18%). Unclassified cases mostly behaved clinically like erythema multiforme.
This large prospective study confirmed that erythema multiforme majus differs from Stevens-Johnson syndrome and toxic epidermal necrolysis not only in severity but also in several demographic characteristics and causes.
有人提出,史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症在皮肤损害的类型和部位上与重症多形红斑有所不同。
评估这种临床分类的有效性。
病例对照研究。
1989年至1995年对欧洲1800个医院科室进行的主动调查。
共552例患者和1720例对照对象。
由对药物暴露及其他因素不知情的专家将病例分为5组(重症多形红斑、史蒂文斯-约翰逊综合征、史蒂文斯-约翰逊综合征-中毒性表皮坏死松解症重叠型、中毒性表皮坏死松解症以及未分类的重症多形红斑或史蒂文斯-约翰逊综合征)。比较这些组间通过病例对照分析得出的疱疹和药物的病因分值。
重症多形红斑在发病年龄较轻的男性中更为常见、复发频繁、发热较少、黏膜损害较轻,且与胶原血管病、人类免疫缺陷病毒感染或癌症无关,这与史蒂文斯-约翰逊综合征、重叠型及中毒性表皮坏死松解症有显著差异。近期或复发性疱疹是重症多形红斑的主要危险因素(病因分值分别为29%和17%),在史蒂文斯-约翰逊综合征中也起一定作用(病因分值为6%和10%),但在重叠型病例或中毒性表皮坏死松解症中不起作用。药物在史蒂文斯-约翰逊综合征、重叠型或中毒性表皮坏死松解症中的病因分值(64%-66%)高于重症多形红斑(18%)。未分类的病例在临床上大多表现类似重症多形红斑。
这项大型前瞻性研究证实,重症多形红斑不仅在严重程度上,而且在一些人口统计学特征和病因方面与史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症不同。